Navigation Links
Partnerships Effective Communicators of Cancer Advances

Treatment guidelines quickly disseminated to community physicians, audit finds

FRIDAY, May 16 (HealthDay News) -- Partnerships between major academic cancer centers and community hospitals are a quick and effective way to spread cancer treatment advances, say researchers at Fox Chase Cancer Center in Philadelphia.

Most new cancer treatments are created at major academic centers and most cancer care is provided at community hospitals, noted the researchers, who conducted a quality control audit of hospitals associated with Fox Chase, a U.S. National Cancer Institute-designated Comprehensive Cancer Center.

The 26 hospitals that are part of the Fox Chase Partners Program have access to the most recent cancer treatment guidelines developed by Fox Chase and other member institutions of the National Comprehensive Cancer Network (NCCN).

"When research leads to significant changes in treatment, it can take years before community oncologists are able to fully adopt the new guidelines. What's unique about the (Fox Chase) Partners program is the timely transition of advances. The audit we conducted shows that our Partner physicians are highly compliant in incorporating recent advances in cancer treatment," Margaret O'Grady, director of care management and clinical operations of Fox Chase Cancer Partners, said in a prepared statement.

She and her colleagues reviewed the medical charts of 124 patients, age 65 or older, treated for stage III colon cancer at Partner hospitals between 2003 and 2006, and found high compliance with NCCN treatment guidelines, including obtaining a minimum of 12 lymph nodes at surgery, and the addition of oxaliplatin to adjuvant chemotherapy.

Almost all patients (123) received adjuvant chemotherapy, although only 76 (61 percent) received oxaliplatin, a chemotherapy agent shown to extend survival in this group of patients.

"At first glance, this number looked low, but as we probed further, we found that all but 11 patients who didn't receive oxaliplatin had documented co-morbidities or other concerns that precluded them from receiving this treatment," O'Grady said.

The audit also found that 74 percent of patients had at least 12 lymph nodes retrieved, which is critically important to cancer treatment planning.

Nearly all the patients (93 percent) received appropriate surveillance with history and physical exams at suggested intervals and routine CEA testing. Abdominal and pelvic surveillance CT was performed in 78 percent of patients.

"We found a drop-off in compliance (49 percent) regarding the documentation of discussions between the doctor and patient about age and life expectancy in relation to adjuvant chemotherapy," O'Grady said. "This discussion is important and informs decision-making."

More information

The U.S. National Cancer Institute has more about cancer therapy.

-- Robert Preidt

SOURCE: Fox Chase Cancer Center, news release, May 15, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
2. Northwestern Memorial Hospital, CAPS, and p4ps Host Consumer Forum to Advance Partnerships to Improve Healthcare Patient Safety
3. Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs
4. Snap Fitness Launches Partnerships with Leading Online Health & Fitness Companies
5. On World AIDS Day, Keeping the Promise to Stop AIDS Through the Power of Partnerships
6. First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions
7. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
8. MGT Capital Investments Announces New Commercial Partnerships for Subsidiary Company Medicexchange PLC
9. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
10. Study shows that administering calcium and magnesium effectively reduces neurological sensitivity
11. Partnership of academic centers and community hospitals effective model for disseminating advances
Post Your Comments:
(Date:11/27/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class ... (Long Term Support) into its Q-Suite 5.10 product line. , Making the change ... version of Asterisk that will receive not only security fixes, but feature and ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... ... , ... Jobs in hospital medical laboratories and in the imaging field lead ... Aureus Medical Group . These fields, as well as travel nursing, ... healthcare jobs through the company’s website, , The leading healthcare staffing ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast ... found on mammography, according to a study published online in the journal Radiology. ... on mammography may necessitate a change in treatment. , Breast MRI is the ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
Breaking Medicine Technology: